top of page

FAQ: How does ValAsta work on PD-L1 Expressed Cancers?

Updated: Oct 5, 2023

Most cancers (85-90%) are PD-L1 expressed cancers. Normal cells have a smooth surface and do not have hair-like PD-L1 ligands on the surface of a cell. These abnormal ligands tend to block the T-Cells, the body’s natural immune fighters from reaching the cancer cell (acting like a wall) - this allows the abnormal cancer cell to reproduce and grow within their own wall (tumors). As detailed in the report linked below, Astaxanthin tends to bind to these PD-L1 ligands. This binding supports the T-cells and B-cells, our bodies natural defense mechanism, to reach and attack the abnormal cancer cell the way they were designed to.

Sam Shepherd explains, in details, how this process works. Click below to download this report.

Astaxanthin and Cancer Cure
Download PDF • 1.19MB

Valasta Store is an online store dedicated to helping everyone suffering from inflammatory conditions and health conditions arising out of oxidative stress. We are not a licensed medical office and do not treat, diagnose, or claim to cure any disease or health condition. Opinions given are those of the presenter and NOT intended as a diagnosis.

30 views0 comments


Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
bottom of page